SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001538210-24-000008
Filing Date
2024-05-20
Accepted
2024-05-20 17:10:54
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20240331.htm   iXBRL 10-Q 699881
2 EX-31.1 nexi-20230930xexx3111.htm EX-31.1 10133
3 EX-31.2 nexi-20230930xexx3121.htm EX-31.2 10357
4 EX-32.1 nexi-20230930xexx3211.htm EX-32.1 3992
5 EX-32.2 nexi-20230930xexx3221.htm EX-32.2 4209
  Complete submission text file 0001538210-24-000008.txt   4950027

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20240331.xsd EX-101.SCH 44780
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20240331_cal.xml EX-101.CAL 43069
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20240331_def.xml EX-101.DEF 174215
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20240331_lab.xml EX-101.LAB 558787
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20240331_pre.xml EX-101.PRE 382696
80 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20240331_htm.xml XML 524414
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 24965655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)